Latest Article

Strong Reactions: Understanding Anaphylactic Allergies

Pharmaceutical firm Mylan made headlines throughout 2016 for the price of its EpiPen®—an epinephrine auto-injector that can stop life-threatening anaphylactic allergic reactions in their tracks. When Mylan acquired the EpiPen in 2007, the device retailed for around $57 apiece; by 2016, a pair of EpiPens set consumers back by about $600. In January, the Federal Trade Commission asked Mylan to provide information to help the agency determine whether Mylan has violated antitrust laws.

SHARE THIS ARTICLE

Taking Aim at Opioid Abuse

The opioid epidemic has found its way into the workplace. Find out what employers are doing to help fight prescription drug abuse.

SHARE THIS ARTICLE